US Patent Issued to Faron Pharmaceuticals on Feb. 17 for "Method for determining potency of therapeutic anti-clever-1 antibody" (Finnish Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,906, issued on Feb. 17, was assigned to Faron Pharmaceuticals Oy (Turku, Finland).

"Method for determining potency of therapeutic anti-clever-1 antibody" was invented by Juho Jalkanen (Mietoinen, Finland), Jami Mandelin (Helsinki) and Matti Karvonen (Turku, Finland).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for determining a potency of a therapeutic anti-Clever-1 antibody or fragment(s) thereof capable of binding to human Clever-1 by inhibition of a modified low-density lipoprotein uptake, wherein the inhibition of modified low-density lipoprotein uptake is an indication of biological activity of said anti-Clever-1 antibody or fragment(...